RiHN
Funding

About
our
funding

Applicants

This research programme seeks to advance high-value applications of redistributed manufacturing research that will transform future deployed medical care capability.

The second call for proposals is now CLOSED.

The deadline was Friday 2nd July 2021, with the expectation of a Sept 2021 project start date (subject to contract). Projects will last for a maximum of 6 months.

Research proposals will advance manufacturing engineering research in one of our four themes, in order of funding priority:

1) Clinical Fluids Manufacturing

2) Cell & Tissue Manufacturing

3) Additive Layer Manufacturing

4) Pharmaceuticals Manufacturing

More details of our themes are available below

Project Collaboration

We also invite organisations involved in advanced manufacturing R&D or providers of emergency and humanitarian care to collaborate with our projects using the ‘project collaboration’ link to provide us with more information.

KEY INFORMATION FOR PROPOSALS

– All proposals must be submitted using our application form
– The programme has budget of around £400,000. There is no set project funding limit but we expect to fund 4-6 projects overall.
– In all cases, funding is only awarded at @80% Full Economic Cost (FEC)
– All submissions must observe guidance provided in each of the four research themes documents
– Applications with match funding from industry or end-user organisations involved in humanitarian, defence or emergency care are actively encouraged.

The RiHN started with a budget of over £1m available for research projects. Following the first round competition and assessments by cross-disciplinary expert panels, RiHN awarded funding to eight successful proposals. These projects commenced in March – April 2021 and will be completed before the end of the year. More details on the successful applicants in the first round are available here.

For our second round, we are prioritising themes that were underrepresented in the first round. Unsuccessful proposals in the first round are not permitted to bid again unless explicitly invited. We reserve the right to close the funding competition earlier or extend deadlines.
Please give full consideration of the time needed to develop your research proposition, secure collaborators, and prepare the necessary institutional information and permissions. RiHN may be able to assist early career researchers to establish links with external partners, although this is not guaranteed and such requests should be made as early as possible. All awards are subject to EPSRC funding rules and institutional acceptance of conditions set out in the guidance.

Please note: if you have any queries about the programme or application process, email Dr Dharm Kapletia or Professor Wendy Phillips.

 

 

Frequently Asked Questions

Prospective Proposals

RiHN is governed by EPSRC rules and is only able to fund UK Higher Education Institutes (HEIs) and qualifying research organisations listed by UKRI here:

https://www.ukri.org/apply-for-funding/before-you-apply/check-if-you-are-eligible-for-research-and-innovation-funding/ 

A) Although we cannot fund your contribution, you can work with a UK university or qualifying research institute and provide a letter of support stating your organisation’s background and interest, any resources you plan to share and how you can help future efforts to translate the research into practice. If you do not have your own links, please contact us and RiHN may be able to facilitate.

A) Funding is not available to support directly allocated staff. It should be used to fund researcher time and related project expenses.

A) Yes, if suitably qualified and experienced. The research can be led by an Early Career Researcher (ECR – within 15 years of doctoral qualification), however, it is expected that at least one permanent senior member of staff will provide oversight.

A) You must demonstrate industrial/practical relevance and ideally include at least one organisational partner(s) operating in relevant areas such as humanitarian, military or emergency medicine. For example, a partner can be a manufacturer, technology firm, public service organisation or non-governmental organisation.

A) Yes. However, the conference must take place within the timeframe of the project and must follow EPSRC rules and UK travel guidance (if applicable).

A) Research proposals are expected to take the form of a feasibility study, proof-of-concept or prototype development and testing - ideally TRL Level 3. RiHN is keen to see proposals showing interest in further progression of technology maturity.

A) Please contact us as soon as possible and provide a summary of your proposed idea to help us advise you further.

Clinical Fluids Manufacturing

This research seeks to address the operational pressures of deployed medical care in austere and extreme environments, where there is often limited access to essential life-saving clinical grade fluids and blood products. Focal areas may include development of innovative production technologies and processes, or adaptation of existing pioneering systems from other high technology sectors. There may be an emphasis on techniques to enhance survivability and transport of fluids and blood. Please read the detailed guidance for more information and apply using the button below.

Cell & Tissue Manufacturing

This research is expected to lead the design and testing of cell and/or tissue interventions that deliver therapeutic effects for the treatment of traumatic injuries or result in improved rehabilitation post-trauma. This might include processes, strategies or devices covering allogeneic or autologous cell therapies, molecules to stimulate specific therapeutic responses from endogenous cell populations or cell and tissue transplantation. Pioneering studies are sought, with a focus on innovative utility under deployed medical care conditions. Please read the detailed guidance for more information and apply using the button below.

Additive Layer Manufacturing

This research is focused on the development and evaluation of field deployable Additive layer Manufacturing processes and systems for the creation of custom medical devices. Proposals may focus attention on where advances in Additive layer Manufacturing could deliver much needed availability of medical equipment, or the (re)design of bespoke products to better respond to emerging threats associated with medical emergencies. Please read the detailed guidance for more information and apply using the button below.

Pharmaceutical Manufacturing

This research seeks to advance the development of miniaturised portable device platform(s) and techniques capable of producing small-molecule active pharmaceutical ingredients (APIs) and therapeutic proteins (e.g. analgesics, anaesthesia, antibiotics) in deployed operations. This may extend to exploring the production of live biotherapeutics targeting the microbiome, the rapid development of vaccine and drugs, and innovative delivery of pharmaceuticals using 3D printers. Please read the detailed guidance for more information and apply using the button below